EW News and Press, Edwards Lifesciences Corporation From 03/07/21

This Edwards Lifesciences (NYSE: EW) report helps investors and traders identify both opportunity, and potential red flags, by using the price action of the stock.  The trading plans for EW have risk controls, and that make these observations both opportunistic and defensive, but t...

How do we know what is going on behind the scenes of a company?  According to Stock Traders Daily, a 20-year industry innovator, the best way to do this to to watch the price action in the stock. The Edwards Lifesciences (NYSE: EW) report below is a real world example. Included are...

Wedgewood Partners’ 13F portfolio value increased from $632M to $672M this quarter. David Rolfe added Progressive while reducing Tractor Supply. Their top five positions are at 39% of the overall portfolio. For further details see: Tracking David Rolfe's Wedgewood...

Fisher’s 13F portfolio value increased from $117.8B to $133.5B in Q4 2020. They increased Alphabet and Total SA during the quarter. Fisher has a number of small positions in several ETFs/ETNs. For further details see: Tracking Ken Fisher's Fisher Asset Management ...

Announcing new data from a prospective study, Edwards Lifesciences (EW) said its bioprosthetic surgical aortic valve with the Resilia tissue platform indicated favorable safety and hemodynamic performance through a median of five years follow-up.The trial involving 689 patients aged 18 a...

Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years PR Newswire AUSTIN, Texas , Jan. 31, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwar...

Edwards Lifesciences (EW) Q4 results:Net sales: $1.19B (+1.7%), Transcatheter Aortic Valve Replacement: $776.2M (+1.8%); Surgical Structural Heart: $204.2M(-0.5%); Critical Care: $198.2M (-0.6%).Net income: $309.5M (+10.5%); EPS: $0.49 (+11%); non-GAAP EPS: ...

Edwards Lifesciences Corporation (EW) Q4 2020 Earnings Conference Call Jan 27, 2021, 05:00 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of America David Lewis - Mo...

Image source: The Motley Fool. Edwards Lifesciences Corp (NYSE: EW) Q4 2020 Earnings Call Jan 27, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Edwards Lifesciences Corp (EW) Q4 2020 Earnings Call Transcript

Edwards Lifesciences (NYSE:EW) is scheduled to announce Q4 earnings results on Wednesday, January 27th, after market close.The consensus EPS Estimate is $0.53 (-63.7% Y/Y) and the consensus Revenue Estimate is $1.18B (+0.9% Y/Y).Over the last 2 years, EW has beaten EPS estimates 75% of the ti...